Lead: Tobacco industry contributions to the development of ultraprocessed food in the United States, 1985–2007: A case study of Lunchables
Tobacco industry contributions to the development of ultraprocessed food in the United States, 1985–2007: A case study of Lunchables American Journal of Public Health Tobacco firms began acquiring US ...
9 Juni 8min
Lead: GLP-1 receptor agonist treatment and health outcomes in methadone-treated patients with opioid use disorder and diabetes
A retrospective comparison of two state-funded smartphone-based contingency management programs with different incentives Drug and Alcohol Dependence This retrospective study compared outcomes for pa...
2 Juni 5min
Lead: Methamphetamine use among adult patients presenting with acute coronary syndrome: A single‐center retrospective cohort study
Methamphetamine use among adult patients presenting with acute coronary syndrome: A single‐center retrospective cohort study🔓 Journal of the American Heart Association This study included 1,309 patie...
27 Maj 7min
Lead: Best practices for hospital-based initiation of medications for opioid use disorder: A consensus statement
Best practices for hospital-based initiation of medications for opioid use disorder: A consensus statement JAMA Network Open This survey study used a 2-round Delphi process to develop expert consensus...
19 Maj 7min
Lead: Access to medications for opioid use disorder among veterans with homeless experience in permanent supportive housing
Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience in Permanent Supportive Housing JAMA Network Open This cohort study assessed 10,110 US veterans with homeless expe...
12 Maj 7min
Lead: Medicaid Managed Care Plan Alignment With State Substance Use Disorder Treatment Coverage Requirements
Medicaid Managed Care Plan Alignment With State Substance Use Disorder Treatment Coverage Requirements The Milbank Quarterly Medicaid managed plan coverage for medications for alcohol use disorders (A...
5 Maj 7min
Lead: Outpatient Direct Initiation of Injectable Buprenorphine in a Harm Reduction Agency and Primary Care Clinic: A Retrospective Case Series
Outpatient Direct Initiation of Injectable Buprenorphine in a Harm Reduction Agency and Primary Care Clinic: A Retrospective Case Series Journal of Addiction Medicine Initiating weekly long-acting inj...
28 Apr 5min
Lead: A µ-opioid receptor superagonist analgesic with minimal adverse effects
A µ-opioid receptor superagonist analgesic with minimal adverse effects Nature This study identifies a novel µ-opioid receptor (MOR) agonist with supramaximal intrinsic efficacy and a unique pharmacol...
21 Apr 7min
